Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

Literature DB >> 32208486

Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

Andre C Kalil¹.

Abstract

Entities: Disease

Year: 2020 PMID： 32208486 DOI： 10.1001/jama.2020.4742

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

153 in total

1. Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.

Authors: Wei Liu; Pengxiang Zhou; Ken Chen; Zhikang Ye; Fang Liu; Xiaotong Li; Na He; Ziyang Wu; Qi Zhang; Xuepeng Gong; Qiyu Tang; Xin Du; Yingqiu Ying; Xiaohan Xu; Yahui Zhang; Jinyu Liu; Yun Li; Ning Shen; Rachel J Couban; Quazi I Ibrahim; Gordon Guyatt; Suodi Zhai
Journal: CMAJ Date: 2020-06-03 Impact factor: 8.262

2. Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology.

Authors: Maicon Falavigna; Verônica Colpani; Cinara Stein; Luciano Cesar Pontes Azevedo; Angela Maria Bagattini; Gabriela Vilela de Brito; José Miguel Chatkin; Sergio Cimerman; Mirian de Freitas Dal Ben Corradi; Clovis Arns da Cunha; Flávia Cordeiro de Medeiros; Haliton Alves de Oliveira Junior; Leandro Genehr Fritscher; Marcelo Basso Gazzana; Débora Dalmas Gräf; Lays Pires Marra; Jessica Yumi Matuoka; Michelle Silva Nunes; Daniela Vianna Pachito; Cássia Garcia Moraes Pagano; Patrícia do Carmo Silva Parreira; Rachel Riera; Amilton Silva; Bruno de Melo Tavares; Alexandre Prehn Zavascki; Regis Goulart Rosa; Felipe Dal-Pizzol
Journal: Rev Bras Ter Intensiva Date: 2020-07-13

3.

Authors: Zhikang Ye; Bram Rochwerg; Ying Wang; Neill K Adhikari; Srinivas Murthy; François Lamontagne; Robert A Fowler; Haibo Qiu; Li Wei; Ling Sang; Mark Loeb; Ning Shen; Minhua Huang; Zhaonan Jiang; Yaseen M Arabi; Luis Enrique Colunga-Lozano; Li Jiang; Younsuck Koh; Dong Liu; Fang Liu; Jason Phua; Aizong Shen; Tianyi Huo; Bin Du; Suodi Zhai; Gordon H Guyatt
Journal: CMAJ Date: 2020-10-26 Impact factor: 8.262

4. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.

Authors: Niveditha Devasenapathy; Zhikang Ye; Mark Loeb; Fang Fang; Borna Tadayon Najafabadi; Yingqi Xiao; Rachel Couban; Philippe Bégin; Gordon Guyatt
Journal: CMAJ Date: 2020-05-22 Impact factor: 8.262

5. Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort.

Authors: Peng Xia; Yubing Wen; Yaqi Duan; Hua Su; Wei Cao; Meng Xiao; Jie Ma; Yangzhong Zhou; Gang Chen; Wei Jiang; Huanwen Wu; Yan Hu; Sanpeng Xu; Hanghang Cai; Zhengyin Liu; Xiang Zhou; Bin Du; Jinglan Wang; Taisheng Li; Xiaowei Yan; Limeng Chen; Zhiyong Liang; Shuyang Zhang; Chun Zhang; Yan Qin; Guoping Wang; Xuemei Li
Journal: J Am Soc Nephrol Date: 2020-08-21 Impact factor: 10.121

10. Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.

Authors: Marko Zdravkovic; Joana Berger-Estilita; Bogdan Zdravkovic; David Berger
Journal: PLoS One Date: 2020-11-05 Impact factor: 3.240

Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

1. Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis.

2. Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology.

3.

4. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis.

5. Clinicopathological Features and Outcomes of Acute Kidney Injury in Critically Ill COVID-19 with Prolonged Disease Course: A Retrospective Cohort.

6. An elderly couple with COVID-19 pneumonia treated in Singapore: contrasting clinical course and management.

7. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline.

8. Facing the SARS-CoV-2 (COVID-19) outbreak with IL-6R antagonists.

9. Ivermectin and COVID-19: Keeping Rigor in Times of Urgency.

10. Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.